BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38040191)

  • 21. Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection.
    Serrano MM; Rodríguez DN; Palop NT; Arenas RO; Córdoba MM; Mochón MDO; Cardona CG
    J Clin Virol; 2020 Aug; 129():104529. PubMed ID: 32659710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of a Prototype SARS-CoV-2 Lateral Flow IMMUNOASSAY with the BinaxNOW
    Hill HJ; Uppal T; Hau D; Pandit SG; Arias-Umana J; Foster AJ; Gorzalski A; Pflughoeft KJ; Burnham-Marusich AR; Reed DE; Gates-Hollingsworth MA; Gumbleton L; Verma SC; AuCoin DP
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detecting Waning Serological Response with Commercial Immunoassays: 18-Month Longitudinal Follow-up of Anti-SARS-CoV-2 Nucleocapsid Antibodies.
    Nakagama Y; Komase Y; Kaku N; Nitahara Y; Tshibangu-Kabamba E; Tominaga T; Tanaka H; Yokoya T; Hosokawa M; Kido Y
    Microbiol Spectr; 2022 Aug; 10(4):e0098622. PubMed ID: 35867423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infection.
    Migueres M; Chapuy-Regaud S; Miédougé M; Jamme T; Lougarre C; Da Silva I; Pucelle M; Staes L; Porcheron M; Diméglio C; Izopet J
    J Med Virol; 2023 Jan; 95(1):e28200. PubMed ID: 36207814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera.
    Ha B; Jadhao S; Hussaini L; Gibson T; Stephens K; Salazar L; Ciric C; Taylor M; Rouphael N; Edupuganti S; Rostad CA; Tompkins SM; Anderson EJ; Anderson LJ
    Microbiol Spectr; 2021 Oct; 9(2):e0045821. PubMed ID: 34494855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A microfluidic biosensor architecture for the rapid detection of COVID-19.
    Muhsin SA; He Y; Al-Amidie M; Sergovia K; Abdullah A; Wang Y; Alkorjia O; Hulsey RA; Hunter GL; Erdal ZK; Pletka RJ; George HS; Wan XF; Almasri M
    Anal Chim Acta; 2023 Sep; 1275():341378. PubMed ID: 37524456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.
    Perico L; Tomasoni S; Peracchi T; Perna A; Pezzotta A; Remuzzi G; Benigni A
    EBioMedicine; 2020 Nov; 61():103069. PubMed ID: 33130396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs.
    Van Elslande J; Decru B; Jonckheere S; Van Wijngaerden E; Houben E; Vandecandelaere P; Indevuyst C; Depypere M; Desmet S; André E; Van Ranst M; Lagrou K; Vermeersch P
    Clin Microbiol Infect; 2020 Nov; 26(11):1557.e1-1557.e7. PubMed ID: 32745595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of commercially available immuno-magnetic agglutination in comparison to enzyme-linked immunosorbent assays for rapid point-of-care diagnostics of COVID-19.
    Moeller ME; Fock J; Pah P; Veras AC; Bade M; Donolato M; Israelsen SB; Eugen-Olsen J; Benfield T; Engsig FN
    J Med Virol; 2021 May; 93(5):3084-3091. PubMed ID: 33547818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.
    DomBourian MG; Annen K; Huey L; Andersen G; Merkel PA; Jung S; Dominguez SR; Knight V
    J Immunol Methods; 2020 Nov; 486():112837. PubMed ID: 32828791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.
    Li Z; Yi Y; Luo X; Xiong N; Liu Y; Li S; Sun R; Wang Y; Hu B; Chen W; Zhang Y; Wang J; Huang B; Lin Y; Yang J; Cai W; Wang X; Cheng J; Chen Z; Sun K; Pan W; Zhan Z; Chen L; Ye F
    J Med Virol; 2020 Sep; 92(9):1518-1524. PubMed ID: 32104917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges in the Detection of SARS-CoV-2: Evolution of the Lateral Flow Immunoassay as a Valuable Tool for Viral Diagnosis.
    Castrejón-Jiménez NS; García-Pérez BE; Reyes-Rodríguez NE; Vega-Sánchez V; Martínez-Juárez VM; Hernández-González JC
    Biosensors (Basel); 2022 Sep; 12(9):. PubMed ID: 36140114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microfluidic Magneto Immunosensor for Rapid, High Sensitivity Measurements of SARS-CoV-2 Nucleocapsid Protein in Serum.
    Li J; Lillehoj PB
    ACS Sens; 2021 Mar; 6(3):1270-1278. PubMed ID: 33629833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies.
    Zedan HT; Yassine HM; Al-Sadeq DW; Liu N; Qotba H; Nicolai E; Pieri M; Bernardini S; Abu-Raddad LJ; Nasrallah GK
    Sci Rep; 2022 Nov; 12(1):19020. PubMed ID: 36347859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
    Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
    J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical performance of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins.
    Favresse J; Cadrobbi J; Eucher C; Elsen M; Laffineur K; Dogné JM; Douxfils J
    J Med Virol; 2021 Apr; 93(4):2262-2269. PubMed ID: 33200836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals with natural and COVID-19 vaccine-induced immunity.
    Thomas SN; Karger AB; Altawallbeh G; Nelson KM; Jacobs DR; Gorlin J; Barcelo H; Thyagarajan B
    Sci Rep; 2022 May; 12(1):8890. PubMed ID: 35614113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of the main haematological indexes and RNA detection for the diagnosis of SARS-CoV-2 infection.
    Xiang J; Chen Z; Zhou J; Tian D; Ran X; Zhang Z; Shi S; Xiao D; Zhou Y
    BMC Infect Dis; 2020 Oct; 20(1):779. PubMed ID: 33081702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.